BTK and B-cell chronic lymphocytic leukemia: In our study, patients with CLL/SLL who received IVIG or BTK inhibitors with or without an anti-CD20 monoclonal antibody in the past 6 months had suboptimal antibody responses to the COVID vaccine, and this is consistent with previous findings [7,14,15].